Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer

Anticancer Research

Volumn 18, Issue 4 C, 1998, Pages 3087-3092

  Miyake, Hideaki ^a,b   Hara, Isao ^a   Gohji, Kazuo ^a   Yamanaka, Kazuki ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY   (Japan)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Adenoviral mediated p53 gene transfer; Apoptosis; Bladder cancer; Cisplatin

Indexed keywords

CISPLATIN; PROTEIN P21; PROTEIN P53;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CHEMOSENSITIVITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG SCREENING ASSAYS, ANTITUMOR; GENE TRANSFER TECHNIQUES; GENES, P53; HUMANS; MALE; MICE; MICE, INBRED BALB C; MUTATION; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0031812996     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Trasher JB and Crawford ED: Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 149: 957, 1993.
2. Logothetis CJ: The role of chemotherapy in the management of invasive bladder cancer. Eur Urol 14: 19, 1988.
3. Sternberg CN, Arena MG, Calabresi FC, Carli PD, Platania A, Massimo Z, Giannarelli D, Cancrini A and Pansadoro V: Neoadjuvant M-VAC (methotrexate, vinblastin, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of bladder. Cancer 72: 1975, 1993.
4. Welsh MJ, Smith AE, Zabner J, Rich DP, Graham SM, Gregory RJ, Pratt BM and Moscicki RA: Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Human Gene Ther 5: 209, 1994.
5. INK4 gene mediated by an adenovirus vector. Cancer Res 55: 3250, 1995.
6. Eastham JA, Hall SJ, Sehgal I, Wang J, Timme TL, Yang G, Connell-Crowley L Elledge SJ, Zhang W-W, Harper JW and Thompson TC: In vivo gene therapy with p53 of p21 adenovirus for prostate cancer. Cancer Res 55: 5151, 1995.
7. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat Med 3: 313, 1997.
8. Zabner J, Peterson DM, Puga AP, Graham SM, Couture LA, Keyes LD, Lukason MJ, St George JA, Gregory RJ, Smith AE and Welsh MJ: Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nat Genet 6: 75, 1994.
9. Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S and Saya H: Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer. Oncogene 16: 933, 1998.
10. Kawasaki T, Tomita Y, Bilim V, Takeda M, Takahashi K and Kumanishi T: Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations. Int J Cancer 68: 501, 1996.
11. Zhang WW, Fang X, Branch CD, Mazur W, French BA and Roth JA: Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechniques 15: 868, 1993.
12. Graham FL and Prevec L: Manipulation of adenovirus vectors. In: Methods in molecular biology, gene transfer and expression protocols (Murray EJ, eds). New Jersey, The Humana Press Inc, 1991, pp 109-128.
13. Miyake H, Hara I, Gohji K, Arakawa S and Kamidono S: p53 modulation of Fas/Apo-l mediated apoptosis in a human renal cell carcinoma cell line. Int J Oncol 12: 469, 1998.
14. Ogretmen B and Safa AR: Expression of the mutated p53 tumor supressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells. Oncogene 14: 499, 1997.
15. Chresta CM, Masters JRW and Hickman JA: Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax: Bcl-2 ratio. Cancer Res 56: 1834, 1996.
16. WAF1-CIP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11: 1899, 1995.
17. WAF1/CIP1 protects against p53-mediated apoptosis of human melanoma cells. Oncogene 14: 929, 1997.